0001676056-17-000002.txt : 20170131 0001676056-17-000002.hdr.sgml : 20170131 20170131132834 ACCESSION NUMBER: 0001676056-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170131 DATE AS OF CHANGE: 20170131 EFFECTIVENESS DATE: 20170131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerus Endovascular Ltd CENTRAL INDEX KEY: 0001676056 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-279669 FILM NUMBER: 17560359 BUSINESS ADDRESS: STREET 1: JOHN ECCLES HOUSE STREET 2: OXFORD SCIENCE PARK CITY: OXFORD STATE: X0 ZIP: OX44G8 BUSINESS PHONE: 44(0)1865578597 MAIL ADDRESS: STREET 1: JOHN ECCLES HOUSE STREET 2: OXFORD SCIENCE PARK CITY: OXFORD STATE: X0 ZIP: OX44G8 D 1 primary_doc.xml X0707 D LIVE 0001676056 Cerus Endovascular Ltd JOHN ECCLES HOUSE OXFORD SCIENCE PARK OXFORD X0 UNITED KINGDOM OX44G8 44(0)1865578597 UNITED KINGDOM None None Other Formed as a private limited Company under the laws of England and Wales. true David Jennings c/o Cerus Endovascular Ltd John Eccles House, Oxford Science Park Oxford X0 UNITED KINGDOM OX4 4GP Executive Officer Franklin Berger c/o Cerus Endovascular Ltd John Eccles House, Oxford Science Park Oxford X0 UNITED KINGDOM OX4 4GP Director Paul A. Brooke c/o Cerus Endovascular Ltd John Eccles House, Oxford Science Park Oxford X0 UNITED KINGDOM OX4 4GP Director J Todd Derbin c/o Cerus Endovascular Ltd John Eccles House, Oxford Science Park Oxford X0 UNITED KINGDOM OX4 4GP Director Sam J. Milstein c/o Cerus Endovascular Ltd John Eccles House, Oxford Science Park Oxford X0 UNITED KINGDOM OX4 4GP Director Biotechnology Decline to Disclose 06b false 2017-01-23 false true true true false 100000 International Alliances Limited None None None 1-5-12-101, Kita Aoyama, Minato-Ku, Tokyo M0 JAPAN 107-0061 true 5000000 2394982 2605018 false 11 0 20000 true Sales Commission applies only to amounts invested from certain Japanese investors. 0 false Cerus Endovascular Ltd /s/ David Jennings David Jennings Chief Financial Officer of the Issuer 2017-01-31